ANDOSAN Trademark

Trademark Overview


On Friday, February 17, 2023, a trademark application was filed for ANDOSAN with the United States Patent and Trademark Office. The USPTO has given the ANDOSAN trademark a serial number of 79364782. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by Mycotech Pharma AS. The ANDOSAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary and nutritional supplements; health food supplements for humans; nutraceuticals for use as dietary supplements
andosan

General Information


Serial Number79364782
Word MarkANDOSAN
Filing DateFriday, February 17, 2023
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383414
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations and natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary and nutritional supplements; health food supplements for humans; nutraceuticals for use as dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMycotech Pharma AS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNO

Party NameMycotech Pharma AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNO

Party NameMycotech Pharma AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNO

Trademark Events


Event DateEvent Description
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Thursday, March 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 14, 2023APPLICATION FILING RECEIPT MAILED
Monday, November 27, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 28, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 29, 2023REFUSAL PROCESSED BY MPU
Wednesday, November 29, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 19, 2023REFUSAL PROCESSED BY IB
Tuesday, December 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2024NOTIFICATION PROCESSED BY IB
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 14, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, January 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED